Madrigal Pharmaceuticals Inc (MDGL)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: MDGL Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
4,866 -2.6%
248.59
1,209,642 USD 		4,866 -2.6% 248.59 1,209,642 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
3,464 -1.8%
247.76
858,241 USD 		3,464 -1.8% 247.76 858,241 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
5,028 -2.5%
246.96
1,241,710 USD 		5,028 -2.5% 246.96 1,241,710 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
2,078 -1.0%
245.71
510,591 USD 		2,078 -1.0% 245.71 510,591 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
5,663 -2.7%
244.86
1,386,646 USD 		5,663 -2.7% 244.86 1,386,646 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
3,730 -1.8%
244.12
910,566 USD 		3,730 -1.8% 244.12 910,566 USD
2024-04-10 2024-04-08 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
1,441 -0.7%
242.95
350,094 USD 		1,441 -0.7% 242.95 350,094 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
200 -0.0%
248.58
49,716 USD 		200 -0.0% 248.58 49,716 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
407 -0.1%
247.76
100,838 USD 		407 -0.1% 247.76 100,838 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
600 -0.1%
246.98
148,186 USD 		600 -0.1% 246.98 148,186 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
300 -0.1%
245.69
73,706 USD 		300 -0.1% 245.69 73,706 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
945 -0.2%
244.79
231,325 USD 		945 -0.2% 244.79 231,325 USD
2024-04-10 2024-04-08 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
224 -0.0%
243.25
54,487 USD 		224 -0.0% 243.25 54,487 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
5,278 -1.1%
245.53
1,295,924 USD 		5,278 -1.1% 245.53 1,295,924 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
2,079 -0.4%
244.45
508,213 USD 		2,079 -0.4% 244.45 508,213 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
8,989 -1.9%
243.33
2,187,288 USD 		8,989 -1.9% 243.33 2,187,288 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
8,817 -1.8%
242.61
2,139,069 USD 		8,817 -1.8% 242.61 2,139,069 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
700 -0.1%
241.14
168,799 USD 		700 -0.1% 241.14 168,799 USD
2024-04-05 2024-04-05 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
1,643 -0.3%
240.11
394,497 USD 		1,643 -0.3% 240.11 394,497 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
444 -0.2%
245.92
109,189 USD 		444 -0.2% 245.92 109,189 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
5,228 -2.7%
245.35
1,282,669 USD 		5,228 -2.7% 245.35 1,282,669 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
3,966 -2.0%
244.22
968,588 USD 		3,966 -2.0% 244.22 968,588 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
9,264 -4.5%
243.20
2,253,016 USD 		9,264 -4.5% 243.20 2,253,016 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
6,679 -3.2%
242.42
1,619,098 USD 		6,679 -3.2% 242.42 1,619,098 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
612 -0.3%
241.15
147,582 USD 		612 -0.3% 241.15 147,582 USD
2024-04-05 2024-04-05 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
1,420 -0.7%
240.10
340,939 USD 		1,420 -0.7% 240.10 340,939 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
100 -0.0%
248.23
24,823 USD 		100 -0.0% 248.23 24,823 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
711 -0.2%
247.23
175,778 USD 		711 -0.2% 247.23 175,778 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
1,653 -0.4%
246.01
406,658 USD 		1,653 -0.4% 246.01 406,658 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
2,734 -0.6%
245.06
670,006 USD 		2,734 -0.6% 245.06 670,006 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
435 -0.1%
244.01
106,143 USD 		435 -0.1% 244.01 106,143 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
3,085 -0.7%
242.71
748,765 USD 		3,085 -0.7% 242.71 748,765 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
5,619 -1.2%
241.85
1,358,971 USD 		5,619 -1.2% 241.85 1,358,971 USD
2024-04-05 2024-04-04 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
4,200 -0.9%
240.88
1,011,679 USD 		4,200 -0.9% 240.88 1,011,679 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
200 -0.1%
248.43
49,685 USD 		200 -0.1% 248.43 49,685 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
737 -0.4%
247.14
182,141 USD 		737 -0.4% 247.14 182,141 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
1,558 -0.8%
246.13
383,471 USD 		1,558 -0.8% 246.13 383,471 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
2,549 -1.3%
245.14
624,857 USD 		2,549 -1.3% 245.14 624,857 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
627 -0.3%
244.31
153,185 USD 		627 -0.3% 244.31 153,185 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
1,467 -0.8%
243.00
356,482 USD 		1,467 -0.8% 243.00 356,482 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
5,299 -2.7%
242.25
1,283,679 USD 		5,299 -2.7% 242.25 1,283,679 USD
2024-04-05 2024-04-04 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
6,273 -3.1%
241.07
1,512,222 USD 		6,273 -3.1% 241.07 1,512,222 USD
2024-04-05 2024-04-03 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
2,089 -0.5%
246.32
514,573 USD 		2,089 -0.5% 246.32 514,573 USD
2024-04-05 2024-04-03 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
18,917 -3.9%
245.34
4,641,014 USD 		18,917 -3.9% 245.34 4,641,014 USD
2024-04-05 2024-04-03 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
4,070 -0.8%
244.68
995,854 USD 		4,070 -0.8% 244.68 995,854 USD
2024-04-05 2024-04-03 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
2,634 -0.5%
243.68
641,866 USD 		2,634 -0.5% 243.68 641,866 USD
2024-04-05 2024-04-03 PS Planned sale

Taub Rebecca

Pres., R&D, and CMO

Executive Director
135 -0.0%
242.00
32,670 USD 		135 -0.0% 242.00 32,670 USD
2024-04-05 2024-04-03 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
1,821 -1.0%
246.31
448,530 USD 		1,821 -1.0% 246.31 448,530 USD
2024-04-05 2024-04-03 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
18,806 -9.1%
245.34
4,613,823 USD 		18,806 -9.1% 245.34 4,613,823 USD
2024-04-05 2024-04-03 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
4,301 -2.0%
244.58
1,051,959 USD 		4,301 -2.0% 244.58 1,051,959 USD
2024-04-05 2024-04-03 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
2,294 -1.1%
243.64
558,921 USD 		2,294 -1.1% 243.64 558,921 USD
2024-04-05 2024-04-03 PS Planned sale

FRIEDMAN PAUL A

Non-Executive Director
185 -0.1%
242.00
44,770 USD 		185 -0.1% 242.00 44,770 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
200 -14.3%
248.45
49,690 USD 		200 -14.3% 248.45 49,690 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
43 -3.0%
247.03
10,622 USD 		43 -3.0% 247.03 10,622 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
557 -27.9%
246.30
137,187 USD 		557 -27.9% 246.30 137,187 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
2,991 -60.0%
244.89
732,480 USD 		2,991 -60.0% 244.89 732,480 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
6,279 -55.7%
244.19
1,533,286 USD 		6,279 -55.7% 244.19 1,533,286 USD
2024-04-03 2024-04-02 PS Planned sale

Daly James M

Non-Executive Director
842 -7.0%
243.26
204,821 USD 		842 -7.0% 243.26 204,821 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
7 -0.6%
249.05
1,743 USD 		7 -0.6% 249.05 1,743 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
193 -13.8%
248.49
47,958 USD 		193 -13.8% 248.49 47,958 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
100 -6.7%
246.88
24,688 USD 		100 -6.7% 246.88 24,688 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
567 -27.5%
246.20
139,597 USD 		567 -27.5% 246.20 139,597 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
2,080 -50.2%
244.97
509,527 USD 		2,080 -50.2% 244.97 509,527 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
7,048 -63.0%
244.27
1,721,630 USD 		7,048 -63.0% 244.27 1,721,630 USD
2024-04-03 2024-04-02 PS Planned sale

BATE KENNETH

Non-Executive Director
1,217 -9.8%
243.28
296,075 USD 		1,217 -9.8% 243.28 296,075 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
274 -18.6%
266.91
73,132 USD 		274 -18.6% 266.91 73,132 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
500 -25.4%
265.49
132,743 USD 		500 -25.4% 265.49 132,743 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
351 -15.1%
264.89
92,977 USD 		351 -15.1% 264.89 92,977 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
178 -7.1%
263.31
46,870 USD 		178 -7.1% 263.31 46,870 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
800 -24.2%
262.01
209,604 USD 		800 -24.2% 262.01 209,604 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
200 -5.7%
259.11
51,822 USD 		200 -5.7% 259.11 51,822 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
1,460 -29.4%
258.28
377,094 USD 		1,460 -29.4% 258.28 377,094 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
3,604 -42.1%
257.30
927,302 USD 		3,604 -42.1% 257.30 927,302 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
7,401 -46.4%
256.50
1,898,371 USD 		7,401 -46.4% 256.50 1,898,371 USD
2024-04-03 2024-04-01 PS Planned sale

Daly James M

Non-Executive Director
6,809 -29.9%
255.64
1,740,630 USD 		6,809 -29.9% 255.64 1,740,630 USD